My Account
Rosiglitazone reduces insulin resistance, an underlying defect of type 2 diabetes.
More information

Subcategories 1

Official product site with information primarily intended for diabetics. Includes patient and prescribing information.
Features information about dosage, usage, warnings, and side effects.
Potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes. (May 21, 2007)
Features information about dosage, usage, warnings, and side effects.
Official product site with information primarily intended for diabetics. Includes patient and prescribing information.
Potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes. (May 21, 2007)
Last update:
October 18, 2016 at 10:54:09 UTC
Health
Home
News
Recreation
Reference
Regional
Science
Shopping
Society
Sports
All Languages
Arts
Business
Computers
Games